› Forums › General Melanoma Community › Phase I Dose Escalation Study and Biomarker Analysis of E7080
- This topic has 4 replies, 2 voices, and was last updated 13 years, 9 months ago by FormerCaregiver.
- Post
-
- March 11, 2011 at 5:27 am
The results of a new phase I study of E7080 suggest anti-angiogenic activity
that is "… correlated with anti-tumor activity in patients with a wide
range of solid tumors".The abstract can be found at:
http://clincancerres.aacrjournals.org/content/early/2011/03/03/1078-0432.CCR-10-2638.abstractFrank
The results of a new phase I study of E7080 suggest anti-angiogenic activity
that is "… correlated with anti-tumor activity in patients with a wide
range of solid tumors".The abstract can be found at:
http://clincancerres.aacrjournals.org/content/early/2011/03/03/1078-0432.CCR-10-2638.abstractFrank
Viewing 1 reply thread
- Replies
Viewing 1 reply thread
- You must be logged in to reply to this topic.